IL10 and Alzheimer disease: Thus, our results suggest that, despite increased frequencies of circulating ICOS+ Tregs in AD, their efficacy of immunosuppression might be impaired due to reduced viability upon restimulation which would, in turn, lead to impaired production of IL‐10.